SEC Form 4 · accession 0001562180-17-002923
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karen Flynn
Officer — Sr VP & Chief Commercial Offic
Period of report
Sep 8, 2017
Accepted (ET)
Sep 11, 2017 · 9:09 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 8, 2017 | A | 8 | $91.43 | A | 1,252 | I | Non-Qualified Deferred Compensation Plan |
| Common Stock | holding | — | — | — | 17,716 | D | ||
| Common Stock | holding | — | — | — | 252 | I | By Savings Plan |
Table II — derivative securities
No Table II lines on this filing.